Senior programme leaders reviewing delivery evidence and a milestone plan in a bright meeting room

    Programme Delivery Assurance Framework: What Executives Should Review

    A programme can appear on track while its evidence, assumptions or decision routes remain weak. A programme delivery assurance framework gives executives a structured, independent way to test whether delivery is credible, risks are visible and decisions are being made by the right people. It informs decisions; it does not transfer accountability away from leaders who own the programme.

    Discuss your programme assurance needs

    What is a programme delivery assurance framework?

    It is a repeatable approach for examining whether a programme is set up and progressing in a way that supports its intended outcomes. Assurance is more than a summary of reported status. It tests the foundations beneath that status: governance, evidence, risks, dependencies, milestones, decisions and the quality of challenge.

    The reviewer should be sufficiently independent of day-to-day delivery to question assumptions without owning the work being assessed. Independence does not mean detachment from context. The reviewer needs access to relevant plans, records, delivery teams and decision-makers, and should understand the programme’s operating environment.

    Executives remain accountable for accepting recommendations, approving changes and deciding whether the programme can proceed. An assurance review informs those decisions; it does not make them on the leaders’ behalf. In practice, this means that the review can report a concern about readiness, but the designated sponsor or governance body must decide how to respond.

    For a discussion about an independent review, the verified contact page is https://www.mustardseedpmo.com/contact-our-project-management-experts-mustardseed-pmo.

    How is assurance different from governance and status reporting?

    These practices support delivery in different ways. Governance defines authority and decision rights. Status reporting communicates what teams say is happening. Assurance tests whether the underlying arrangements and evidence justify that account. A PMO governance framework can define how decisions are structured, while assurance asks whether those arrangements work for this programme.

    ActivityMain questionTypical focusAccountability
    Programme governanceWho can decide, and how?Forums, roles, escalation and approvalsNamed executives and governance bodies
    Status reportingWhat is reported about progress?Milestones, issues, actions and forecastsDelivery leads produce and validate reports
    Delivery assuranceIs the reported position credible and controlled?Evidence, assumptions, risk response, decision quality and control effectivenessIndependent reviewer provides findings; accountable owners decide what to do
    Maturity assessmentHow developed are organisational practices?Capabilities, processes and improvement opportunitiesLeaders sponsor capability changes

    An assurance review may identify a governance weakness, but its purpose is not to design the whole governance model. It may challenge a red or green status, but it is not a replacement reporting system. And while it can surface capability gaps, it is not a broad maturity scorecard. A wider PMO assessment can examine capability across an operating model; an assurance review stays focused on whether a particular programme’s claims and controls hold up.

    What should an independent review examine?

    Governance and decision rights

    Start by checking whether the programme has clear authority and usable decision routes. A diagram of committees is not enough. Test whether the people involved know which decisions they own, what evidence they need, and when an issue must be escalated.

    • Are the executive sponsor, senior responsible owner and delivery leads identified in a way that fits the organisation?
    • Do approval thresholds and escalation triggers reflect the scale and exposure of the work?
    • Are decisions recorded with rationale, conditions, owners and due dates?
    • Can a decision be revisited when evidence or assumptions change?
    • Are unresolved cross-functional decisions brought to the right forum promptly?

    Look at recent decisions, not only the written terms of reference. If a committee is meant to decide whether to release a stage, sample the record: Was the decision made by the authorised people? Was the evidence available beforehand? Were conditions or follow-up actions recorded? A process exists on paper only if people can use it when a consequential choice is due.

    For regulated programmes, confirm that appropriate quality, regulatory, operational and technical voices are included where decisions affect their responsibilities. Assurance should examine whether required control and review routes operate in practice, without claiming that the reviewer owns regulatory approval. The accountable function continues to make its own approval decision.

    Evidence behind the reported position

    Ask what supports key claims, not merely whether a dashboard is complete. Evidence should be current, traceable to a source and relevant to the decision at hand. A milestone marked complete might require an approved deliverable, an acceptance record, a test result or another defined proof point. The appropriate evidence depends on the work and the completion criteria agreed in advance.

    Trace a sample of material claims from the executive report back to source records. Check whether forecasts are supported by actual progress, whether assumptions are explicit, and whether exceptions are visible. Where evidence is incomplete, state exactly what is missing and what conclusion cannot yet be drawn. Do not treat a polished presentation as proof in itself.

    Programme team examining milestone evidence and risks during an assurance review

    Risks, issues and dependencies

    Review whether the programme has a practical method for identifying, assigning and responding to uncertainty. A long risk register can still be weak if owners lack authority, responses are overdue or dependencies are treated as someone else’s concern.

    • Do material risks have named owners, response actions and review dates?
    • Are triggers and potential consequences clear enough to support escalation?
    • Are issues distinguished from risks and acted on at the appropriate level?
    • Are dependencies between workstreams, suppliers, sites or functions mapped and actively managed?
    • Do contingency plans address plausible failure points, not just routine variation?

    For example, a life sciences programme may rely on several functions completing work in sequence before a milestone can be accepted. The assurance reviewer can test the dependency, readiness evidence and owner’s response plan rather than accepting a date because it appears in the integrated plan. The accountable leaders decide whether to change scope, sequence, resources or timing. For a related operating context, see what a pharmaceutical PMO does and this overview of project management for pre-IND readiness.

    Milestones, schedule logic and intended outcomes

    Milestones matter when they represent meaningful progress toward an outcome. Review the logic connecting activities to milestones and milestones to benefits. Check that forecast dates account for dependencies, review cycles, resourcing and known constraints. A date without a defined completion condition is difficult to assure.

    Sample a small number of critical milestones. Compare the baseline, latest forecast, completion criteria and evidence. Look for repeated movement, compressed review time, hidden rework or a mismatch between the plan and the capacity available. Ask what the milestone unlocks: a decision, a validated capability, operational readiness or another defined outcome? Assurance should describe the implications and confidence limits, not present a forecast as certainty.

    Where a programme has several parallel workstreams, trace one milestone across the plan. Identify its predecessor activities, review or acceptance points, owners and downstream dependencies. If a date moved, establish whether the cause was a changed assumption, an incomplete deliverable, resource contention or an external dependency. The purpose is not to allocate blame. It is to give executives an accurate picture of what the change means and which decisions are now time-sensitive.

    Decisions and executive challenge

    Good assurance makes executive challenge specific. It identifies the claim being tested, the evidence considered, the uncertainty that remains and the decision that may be needed. The reviewer should ask whether leaders received material information in time to act, and whether challenge led to a recorded response.

    Challenge should be proportionate and constructive. The objective is not to catch individuals out. It is to expose weak assumptions early, clarify choices and strengthen control. When the reviewer identifies a concern, the accountable owner should respond with an action, an accepted risk or a reasoned disagreement. That response belongs in the record. A clear project leadership approach helps make ownership and escalation visible, but assurance still tests whether the approach is working in the specific programme.

    Executives and an independent reviewer discussing programme assumptions and decisions

    How can leaders structure an assurance cycle?

    A useful framework links the review to decisions the programme actually faces. A fixed calendar can provide rhythm, but assurance should also respond to material changes such as a major scope shift, a critical milestone, a new dependency or a change in risk exposure. Use the smallest review that can answer the decision question reliably; expand the scope when evidence points to connected problems.

    1. Set the question and scope. Define the decision or delivery concern the review will address. Specify the workstreams, period, evidence and exclusions. For example, “Is the programme ready to enter the next stage?” is more useful than “Review the programme” because it identifies the decision context.
    2. Confirm independence and access. Identify who will conduct the review, disclose relevant involvement and arrange access to records and people. Avoid assigning the reviewer ownership of the delivery they assess.
    3. Agree criteria in advance. State what credible control looks like for governance, evidence, risks, milestones and decisions. Tailor the criteria to programme context and the decision at hand.
    4. Gather and test evidence. Review plans and records, trace selected claims to sources, and speak with people who create, use or approve the information. Record the sample and any access limits.
    5. Validate emerging findings. Check factual accuracy with delivery owners while keeping the reviewer responsible for independent conclusions. Give owners a chance to explain context, not a veto over findings.
    6. Report implications and actions. Separate observed facts, analysis, uncertainty and recommendations. Assign each action to an accountable owner with a due date.
    7. Track decisions and closure. Record what executives accepted, changed, deferred or rejected, and verify whether agreed actions have been completed effectively.

    Consider a hypothetical stage-gate decision where an executive team must decide whether to authorise the next phase. A focused assurance cycle could test three things: whether the gate criteria are explicit, whether a sample of evidence satisfies those criteria, and whether unresolved dependencies have owners and credible responses. The report would then set out the evidence reviewed, gaps, options and consequences. Executives—not the reviewer—decide whether to proceed, proceed with conditions, defer or change the plan.

    The cycle should be light enough to use and rigorous enough to support consequential decisions. It can align with existing programme reviews rather than create another standing meeting. The key is to preserve the distinction between reporting a position and independently testing it. A foundational PMO approach may establish common processes and templates, while operational PMO services support delivery visibility; neither removes the need for independent challenge when executives need assurance.

    What should an assurance report tell executives?

    A concise report should make the conclusion understandable without hiding the basis for it. Include:

    • the review question, scope, date and criteria;
    • the evidence examined and any important limits on access or sampling;
    • an overall conclusion with a clear explanation, not a bare colour rating;
    • findings grouped by significance and linked to evidence;
    • the effect on outcomes, timing, cost, compliance or operational readiness where relevant;
    • actions, named owners and target dates;
    • decisions required from executives, including choices and consequences;
    • any response from accountable owners and unresolved disagreement.

    A useful finding connects condition, evidence and consequence. Instead of “dependency management needs improvement,” state which dependency is not confirmed, what evidence is missing, the milestone it affects and the decision or action required. Keep recommendations within the review’s remit. If the finding concerns a broader capability gap, leaders may choose a separate capability review; an assessment such as the PMO assessment questionnaire addresses a different question from assurance of a specific programme.

    Make uncertainty explicit. If a conclusion depends on an unverified assumption, say so. If evidence is unavailable, distinguish absence of evidence from evidence that a control failed. This discipline helps executives calibrate confidence and act without overstating what a review can establish. Record whether the report is based on a sample, what was not examined and why those limits matter to the conclusion.

    How do organisations make the framework useful?

    Begin with the programme’s exposure and decision needs. A major regulated initiative with multiple workstreams may need deeper sampling of evidence and dependencies than a smaller, stable programme. The framework should be consistent enough for comparisons but flexible enough to test the risks that matter in each context. Leaders can build on a project management best-practices playbook for shared working practices without treating a template as a substitute for judgement.

    Useful working practices include maintaining a central evidence index, recording decisions in a consistent log and linking material risks to milestones and owners. Tools can support traceability, but the framework depends on clear criteria, honest reporting and timely executive action. Dashboards should make source information easier to inspect, not obscure where a number came from or who is responsible for it.

    Leaders should also make the follow-through visible. At the next review, check whether actions were completed, whether the control changed in practice and whether the original concern remains. An action marked complete is not necessarily effective; look for evidence of the intended change. If leaders accept a risk instead of taking action, record who accepted it, the rationale and when it will be reconsidered.

    External guidance can help frame review discipline without substituting for programme-specific judgement. The Australian Government’s overview of delivery confidence assessment describes assurance as a way to provide government with confidence about whether digital projects are on track to deliver expected outcomes and benefits. The context is specific, but the principle is useful: confidence should be assessed against delivery evidence and intended outcomes. For a second perspective on organising assurance arrangements, see the professional public finance body CIPFA’s briefing on developing an assurance framework.

    Broader practices should remain distinct. A PMO maturity assessment can help leaders consider how established their organisation’s practices are. Strategic PMO support may help connect initiatives to executive priorities through strategic PMO services. Assurance, by contrast, tests the credibility and control of a defined programme at a particular point or across an agreed cycle.

    Where do assurance frameworks commonly fail?

    • Assurance becomes a status meeting. The review repeats dashboard messages without testing evidence. Make source tracing and sample testing part of the method.
    • The reviewer is not independent enough. A person who owns delivery decisions may struggle to challenge their own assumptions. Separate review responsibility from approval and execution, and disclose any limits to independence.
    • Findings are too vague. Statements such as “improve governance” do not tell an owner what to do. Link each finding to evidence, consequence and a practical action.
    • Executives receive findings too late. A report after the decision window cannot support meaningful challenge. Align review timing to decision points and escalate urgent concerns promptly.
    • Recommendations obscure accountability. A reviewer advises; accountable executives decide whether and how to act. Record acceptance, rejection or deferral and the rationale.
    • Every programme uses the same depth. A uniform checklist may miss context. Apply consistent principles, then scale the review to risk and complexity.
    • Actions close on paper only. A completed task does not prove that a control now works. Verify the result against the original concern and record any remaining exposure.

    Frequently asked questions

    Who should conduct programme delivery assurance?

    A reviewer or review team with appropriate experience and sufficient independence from the work being examined should conduct it. The programme’s accountable leaders retain final authority over decisions and actions. Where internal knowledge is essential, disclose potential conflicts and protect the independence of conclusions.

    How often should a programme be reviewed?

    Set a cadence that supports major decisions and key milestones, then add reviews when material changes in scope, risk or delivery confidence warrant them. The right interval depends on programme complexity and exposure. Avoid reviewing so frequently that teams cannot act on findings, or so rarely that important decisions pass without evidence-based challenge.

    Is assurance the same as an audit?

    No. Assurance may use evidence examination and structured testing, but its scope and criteria are defined for the programme’s delivery confidence and decisions. Do not describe it as a formal audit unless it is conducted under the applicable audit mandate and standards.

    Can an assurance reviewer approve a programme to proceed?

    The reviewer can provide findings and recommendations, but approval belongs to the designated accountable decision-makers. They should consider the evidence, uncertainties, options and consequences before deciding. A reviewer can state what the evidence supports and what remains uncertain, but cannot assume the sponsor’s decision authority.

    What is the difference between an assurance framework and a maturity assessment?

    An assurance framework tests whether a defined programme’s controls, evidence and delivery claims support confidence at a particular decision point. A maturity assessment considers how developed practices are across an organisation or PMO. The results may inform each other, but they answer different questions.

    For further reading, explore how PMO as a Service can support complex system upgrades, Smartsheet dashboards for executive project visibility and when consulting project management is useful.

    Explore programme delivery in pharmaceutical settings

    A strong assurance framework helps leaders see beyond reported status to the evidence, risks and decisions that shape delivery confidence. Its value depends on independent challenge, clear records and executives who remain accountable for what happens next.

    Steve Curry, Founder & CEO of MustardSeed PMO
    About the Author
    Steve Curry is the Founder & CEO of MustardSeed PMO. With 20+ years of project management experience, he led a 100+ person PMO at one of the world's largest pharmaceutical companies before founding MustardSeed PMO to deliver embedded project leadership to life sciences, biotech, pharma, and complex industries.